By Admin 
Weight loss medicine: Obesity is a big problem in today’s time, which is causing diabetes to heart diseases. Keeping this problem of the people, Denmark’s drug company Novo Nordisk launched its weight loss drug in India on Tuesday. Its name is Wegovy, which is an injectable semaglutide.
Medication is available in different doses
Glucagon-like Peptide-1 receptor agonist (GLP-1 RA), once a week, is the first and only drug in India to managing vegovi weight, which reduces the risk of long-term chronic weight management and Major Adversus Cardiovascular Events (MACE). It is a pen -resembling device, which is easy to use. It is available in different doses- 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg.
How much is the price?
The drug starts at Rs 17,345 per pen for 0.25 mg, 0.5 mg and 1 mg, while the price of 1.7 mg is Rs 24,280 per pen and 2.4 mg is priced at Rs 26,015 per pen. The company has said that it is a press conference only medicine. That is, a doctor’s slip will be required for this. Vagovi will improve their quality of life by reducing the weight of millions of Indians suffering from obesity or overweight.
How does Vegovi work?
According to India’s study, India has the third largest population of overweight and obesity. The number of people suffering from normal obesity here is 254 million, while there are 351 million people suffering from abdominal obesity.
Wagovi is a GLP-1 receptor of a kind of protein. This reduces hunger and ends cravings. Eventually, its effect starts appearing on weight. This also improves insulin resistance, which improves cardiometabolic system.
Also read:
EPFO made a big announcement, now PF advance will be available up to Rs 5 lakh, know what is the process